The Game-Changing Paradigm Shift in Rescue Therapy for Asthma

CME | CNE | CE 2.00 Credits

Program Description


Asthma affects more than 260 million individuals worldwide and in 2018, asthma actively affected more than 25.2 million people in the United States (7.8% of the population). Of those affected in United States, an estimated 48% have uncontrolled asthma. Approximately 50% of people with current asthma reported having an acute exacerbation within the last 12 months. It is clear that asthma is a suboptimally-managed disease that currently results in significant morbidity, mortality, and expense. One proven strategy to reduce hospitalizations and improve asthma control is to add an inhaled corticosteroid (ICS) to a SABA (AIR therapy) or maintenance and reliever therapy (MART) in place of a rescue SABA alone. Because the strategy of using MART or AIR therapy represents a game changing paradigm shift, effective education is critically needed.

Intended Audience


The target audience includes pulmonologists and allergists / immunologists practicing in various regions across the United States. This may also be of interest to primary care clinicians and pulmonology advanced practice providers and nurses.

Commercial Supporter


Supported by an educational grant from AstraZeneca.